Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.549, 2008-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Dual therapy including a macrolide reduces LOS, costs in CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 416, 2003-01 ,pp. :
Access to resources
Recommend
Antibacterial shift therapy reduces costs of CAP in Italy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 380, 2002-01 ,pp. :
Levofloxacin good choice in CAP
Inpharma, Vol. 1, Iss. 1428, 2004-01 ,pp. :
Nesiritide reduces LOS, costs in heart failure vs milrinone
Inpharma, Vol. 1, Iss. 1411, 2003-01 ,pp. :
Nesiritide reduces LOS, costs in heart failure vs milrinone
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 436, 2003-01 ,pp. :